Date published: 2026-4-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR10J5 Inhibitors

Or10j5 inhibitors encompass a diverse group of compounds, each selected for its ability to modulate the activity of the Or10j5 olfactory receptor. This class is defined not by a shared chemical structure, but by a shared target of action: the modulation of Or10j5's involvement in the olfactory signaling pathway. These inhibitors function by interacting with various components of the G-protein-coupled receptor (GPCR) signaling pathway, which Or10j5 is a part of. The diverse mechanisms of action within this class reflect the complex nature of olfactory signal transduction, requiring a multifaceted approach to effectively influence the receptor's function. The inhibitors in this class include compounds that can interfere with the initial stages of olfactory signal transduction, such as those preventing the binding of specific odorants to Or10j5. Others target the downstream signaling events post-receptor activation. This includes inhibiting the activity of G-proteins that couple with the receptor, thereby blocking the signal transduction cascade initiated by odorant-receptor binding. Additionally, some compounds in this class act on further downstream elements, like enzymes that generate secondary messengers or proteins that mediate cellular responses to these messengers. By targeting these various stages of the olfactory signaling pathway, the inhibitors can effectively modulate the receptor's ability to transduce olfactory signals. This class of inhibitors represents a strategic approach to influencing olfactory perception at the molecular level. By modulating the functionality of a specific olfactory receptor, these compounds can alter the initial and crucial steps of odor detection and signal transduction. The Or10j5 Inhibitors class underscores the intricate relationship between chemical compounds and biological signaling processes. It highlights the depth of understanding required to manipulate specific protein functions within complex biological systems. This approach not only provides insights into the fundamental mechanisms of olfaction but also demonstrates the potential of targeted molecular modulation in studying and influencing specific aspects of sensory perception.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

trans 2-Phenylcyclopropylamine Hydrochloride

1986-47-6sc-208452
sc-208452A
250 mg
1 g
$57.00
$166.00
1
(0)

trans 2-Phenylcyclopropylamine Hydrochloride inhibits adenylate cyclase, potentially reducing cAMP production in response to Or10j5 activation.

KT 5720

108068-98-0sc-3538
sc-3538A
sc-3538B
50 µg
100 µg
500 µg
$138.00
$220.00
$972.00
47
(2)

KT5720 inhibits protein kinase A, which is activated by cAMP in the GPCR pathway of Or10j5.

H-89 dihydrochloride

130964-39-5sc-3537
sc-3537A
1 mg
10 mg
$94.00
$186.00
71
(2)

H-89 inhibits protein kinase A, potentially disrupting the signaling cascade following Or10j5 activation.

Tetracaine

94-24-6sc-255645
sc-255645A
sc-255645B
sc-255645C
sc-255645D
sc-255645E
5 g
25 g
100 g
500 g
1 kg
5 kg
$66.00
$309.00
$500.00
$1000.00
$1503.00
$5000.00
(0)

Tetracaine can block sodium channels, potentially inhibiting the neuronal response to Or10j5 activation.

Amiloride • HCl

2016-88-8sc-3578
sc-3578A
25 mg
100 mg
$22.00
$57.00
6
(2)

Amiloride • HCl blocks certain ion channels, which might affect the signal transduction of Or10j5.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

Pertussis Toxin can inhibit G-proteins, potentially blocking the signaling pathway of Or10j5.

PP1 Analog II, 1NM-PP1

221244-14-0sc-203214
sc-203214A
1 mg
5 mg
$106.00
$530.00
10
(1)

PP1 Analog II, 1NM-PP1 is a potent Gs-alpha subunit inhibitor, which can disrupt GPCR signaling including that of Or10j5.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K, potentially affecting downstream signaling pathways of GPCRs including Or10j5.